Corrigendum to "RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7" [Biochem. Pharmacol. 180 (2020) 114118].
Article
Overview
publication date
published in
Identity
Scopus Document Identifier
Digital Object Identifier (DOI)
-
10.1016/j.bcp.2020.114223
PubMed ID
Additional Document Info
volume